Versione stampabile

Bibliografia

Multilocus VNTR analysis of Mycobacterium ulcerans strains isolated in Côte d'Ivoire.
Coulibaly-N Golo GM, Ekaza E, Coulibaly B, Aka N, N'guessan RK, Thiberge JM, Caro V, Brisse S, Bretin-Dosso M.
J Infect Dev Ctries. 2011 Feb 1;5(1):59-63.

Buruli ulcer. A disabling infection. [No authors listed]
Prescrire Int. 2010 Nov;19(110):261-2.

Activities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in mice.
Almeida D, Converse PJ, Ahmad Z, Dooley KE, Nuermberger EL, Grosset JH.
PLoS Negl Trop Dis. 2011 Jan 4;5(1):e933

Buruli Ulcer: A Review of In Vitro Tests to Screen Natural Products for Activity against Mycobacterium ulcerans. Yemoa A, Gbenou J, Affolabi D, Moudachirou M, Bigot A, Anagonou S, Portaels F, Quetin-Leclercq J, Martin A.
Planta Med. 2011 Jan 14. [Epub ahead of print]

Mycobacterium ulcerans infections cause progressive muscle atrophy and dysfunction, and mycolactone impairs satellite cell proliferation. Houngbédji GM, Bouchard P, Frenette J.

Am J Physiol Regul Integr Comp Physiol. 2011 Mar;300(3):R724-32. Epub 2011 Jan 5.

PMID:
21209381
[PubMed - in process]
6.

Buruli ulcer prevalence and altitude, Benin.

Sopoh GE, Johnson RC, Anagonou SY, Barogui YT, Dossou AD, Houézo JG, Phanzu DM, Tente BH, Meyers WM, Portaels F.

Emerg Infect Dis. 2011 Jan;17(1):153-4. No abstract available.

PMID:
21192889
[PubMed - in process]
Free Article
7.

Ecology and transmission of Buruli ulcer disease: a systematic review.

Merritt RW, Walker ED, Small PL, Wallace JR, Johnson PD, Benbow ME, Boakye DA.

PLoS Negl Trop Dis. 2010 Dec 14;4(12):e911.

PMID:
21179505
[PubMed - in process]
Free PMC Article
8.

All-oral antibiotic treatment for buruli ulcer: a report of four patients.

Gordon CL, Buntine JA, Hayman JA, Lavender CJ, Fyfe JA, Hosking P, Starr M, Johnson PD.

PLoS Negl Trop Dis. 2010 Nov 30;4(11):e770. No abstract available.

PMID:
21152060
[PubMed - in process]
Free PMC Article
9.

Toponymous diseases of Australia.

Appuhamy RD, Tent J, Mackenzie JS.

Med J Aust. 2010 Dec 6-20;193(11-12):642-6.

PMID:
21143049
[PubMed - indexed for MEDLINE]
10.

Buruli Ulcer: Advances in Understanding Mycobacterium ulcerans Infection.

Walsh DS, Portaels F, Meyers WM.

Dermatol Clin. 2011 Jan;29(1):1-8.

PMID:
21095521
[PubMed - in process]
11.

Regulation of the 18 kDa heat shock protein in Mycobacterium ulcerans: an alpha-crystallin orthologue that promotes biofilm formation.

Pidot SJ, Porter JL, Tobias NJ, Anderson J, Catmull D, Seemann T, Kidd S, Davies JK, Reynolds E, Dashper S, Stinear TP.

Mol Microbiol. 2010 Dec;78(5):1216-31. doi: 10.1111/j.1365-2958.2010.07401.x. Epub 2010 Oct 11.

PMID:
21091506
[PubMed - in process]
12.

Antioxidants protect keratinocytes against M. ulcerans mycolactone cytotoxicity.

Grönberg A, Zettergren L, Bergh K, Ståhle M, Heilborn J, Angeby K, Small PL, Akuffo H, Britton S.

PLoS One. 2010 Nov 4;5(11):e13839.

PMID:
21079804
[PubMed - in process]
Free PMC Article
13.

Using bioluminescence to monitor treatment response in real time in mice with Mycobacterium ulcerans infection.

Zhang T, Li SY, Converse PJ, Almeida DV, Grosset JH, Nuermberger EL.

Antimicrob Agents Chemother. 2011 Jan;55(1):56-61. Epub 2010 Nov 15.

PMID:
21078940
[PubMed - in process]
14.

Serological evaluation of Mycobacterium ulcerans antigens identified by comparative genomics.

Pidot SJ, Porter JL, Marsollier L, Chauty A, Migot-Nabias F, Badaut C, Bénard A, Ruf MT, Seemann T, Johnson PD, Davies JK, Jenkin GA, Pluschke G, Stinear TP.

PLoS Negl Trop Dis. 2010 Nov 2;4(11):e872.

PMID:
21072233
[PubMed - in process]
Free PMC Article
15.

A genotypic approach for detection, identification, and characterization of drug resistance in Mycobacterium ulcerans in clinical samples and isolates from Ghana.

Beissner M, Awua-Boateng NY, Thompson W, Nienhuis WA, Klutse E, Agbenorku P, Nitschke J, Herbinger KH, Siegmund V, Fleischmann E, Adjei O, Fleischer B, van der Werf TS, Loscher T, Bretzel G.

Am J Trop Med Hyg. 2010 Nov;83(5):1059-65.

PMID:
21036838
[PubMed - indexed for MEDLINE]
16.

Squamous cell carcinoma secondary to Buruli ulcer: a clinical case report in a young girl.

Kassi K, Kouame K, Allen W, Kouassi LA, Ance W, Kanga JM.

Bacteriol Virusol Parazitol Epidemiol. 2010 Jan-Mar;55(1):25-8.

PMID:
21033631
[PubMed - indexed for MEDLINE]
17.

Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression.

Fraga AG, Cruz A, Martins TG, Torrado E, Saraiva M, Pereira DR, Meyers WM, Portaels F, Silva MT, Castro AG, Pedrosa J.

Infect Immun. 2011 Jan;79(1):421-30. Epub 2010 Oct 25.

PMID:
20974825
[PubMed - indexed for MEDLINE]
18.

Serum cytokine profile during Mycobacterium ulcerans infection (Buruli ulcer).

Zavattaro E, Mesturini R, Dossou A, Melensi M, Johnson RC, Sopoh G, Dianzani U, Leigheb G.

Int J Dermatol. 2010 Nov;49(11):1297-302. doi: 10.1111/j.1365-4632.2010.04615.x.

PMID:
20964651
[PubMed - indexed for MEDLINE]
19.

Fighting mycobacterial infections by antibiotics, phytochemicals and vaccines.

Bamberger D, Jantzer N, Leidner K, Arend J, Efferth T.

Microbes Infect. 2010 Sep 9. [Epub ahead of print]

PMID:
20832501
[PubMed - as supplied by publisher]
20.

[Combined local and vaginal therapy in Buruli ulcer].

Milánkovits M.

Orv Hetil. 2010 Aug 29;151(35):1434-5. Hungarian. No abstract available.

PMID:
20824910
[PubMed - indexed for MEDLINE]

Data pubblicazione: 2011-02-07